SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001016504-14-000012
Filing Date
2014-10-28
Accepted
2014-10-28 17:11:01
Documents
12
Period of Report
2014-10-28
Effectiveness Date
2014-10-28

Document Format Files

Seq Description Document Type Size
1 inbproxy2014.htm DEF 14A 187825
2 inb001.jpg GRAPHIC 31120
3 inb002.jpg GRAPHIC 52359
4 inb003.jpg GRAPHIC 49939
5 inb004.jpg GRAPHIC 114351
6 inb005.jpg GRAPHIC 85106
7 inb006.jpg GRAPHIC 40130
8 inb007.jpg GRAPHIC 34279
9 inb008.jpg GRAPHIC 56679
10 inbaaa1.jpg GRAPHIC 127094
11 inbbbb1.jpg GRAPHIC 12841
12 inbccc1.jpg GRAPHIC 117929
  Complete submission text file 0001016504-14-000012.txt   1184870
Mailing Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE PO BOX 278 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-31668 | Film No.: 141177893
SIC: 2834 Pharmaceutical Preparations